Corrigendum for the article Clin Nephrol. 2025; 103: 1-4 | Canada Hyperbarics Skip to main content
Study Clin Nephrol 2025

Corrigendum for the article Clin Nephrol. 2025; 103: 1-4

Brekke F, der Lippe N, Røed I, Gudmundsdottir H, Braaten M, Nordheim E — Clin Nephrol, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers corrected errors in patient classification and numbers in a previously published study about hyperbaric oxygen treatment for calciphylaxis.

What They Found

The researchers corrected that 15 patients (60%) had end-stage renal disease requiring renal replacement therapy at diagnosis, not 10 patients (40%). They also clarified that five patients were initially misclassified regarding their kidney disease stage while on dialysis. Despite these corrections, the original finding that there was no survival difference between patients on and not on renal replacement therapy remained unchanged.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The primary limitation of this corrigendum is that it addresses errors in patient data from a previous study, indicating potential issues with initial data accuracy and reporting.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 40130883
Year Published 2025
Journal Clin Nephrol
MeSH Terms Humans; Kidney Failure, Chronic; Renal Replacement Therapy; Renal Dialysis; Renal Insufficiency, Chronic

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.